Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06364488Not ApplicableRecruiting

TrueBlue Clinical Study - Investigating the Use of a Mobile Phone App TrueBlue for Monitoring Depression and Anxiety

Role: collaborator

NCT05154019Not ApplicableCompleted

Managing Minds at Work: A Feasibility Pilot Trial

Role: collaborator

NCT02442193Not ApplicableTerminated

Individual Placement and Support for Patients With Offending Histories

Role: collaborator

NCT02016456Not ApplicableCompleted

TMS Treatment for Depression in the National Health Service

Role: lead

NCT02616835Not ApplicableCompleted

Investigating the Physiology of Targeted Theta-burst Neuromodulation

Role: lead

NCT02174952Not ApplicableUnknown

Self-help in Adjunct to Pharmacotherapy

Role: collaborator

All 6 trials loaded